Name: Benzofuran | 6-apb succinate
Availability: InStock

6-APB succinate

6-APB (6-(2-aminopropyl)benzofuran) is an empathogenic psychoactive compound from the class of substituted benzofurans and substituted phenethylamines. 6-APB and other compounds are sometimes informally referred to as "benzofury" in newspaper reports. It has a similar structure to MDA, but differs in that the 3,4-methylenedioxyphenyl ring system has been replaced by a benzofuran ring. 6-APB is also the unsaturated benzofuran derivative of 6-APDB. It may appear as a light brown, granular powder.

Benzofuran | 6-APB succinate

6-APB succinate - also known as 6-(2-aminopropyl) benzofuran or "benzofury" - is a novel empathogen (a chemical that evokes feelings of connectedness and empathy) from the 6-apb succinate class (similar to chemicals such as 5-MAPB and 5-PDB).

6-APB was first synthesized by David Nicholls in 1993, in the hope of finding a non-neurotoxic alternative to MDMA (which can be neurotoxic in humans).

Whether 6-APB is less neurotoxic than MDMA is still controversial, as noted in the September 2020 study "Beyond Ecstasy: Alternative Entactogens to MDMA with Potential Applications in Psychotherapy":

No studies on the neurotoxic potential of Benzofury have been conducted to date.

However, there is some evidence from user reports: It is generally claimed that 6-APB and Benzofury lead to less of a "come-down", a phase following the acute effects of a drug characterized by depressive thoughts, lack of energy and general malaise, than MDMA.

We strongly recommend that you read this study if you are interested in the pharmacology of 6-apb succinate.

It is the most comprehensive analysis to date of this chemical class and its similarities and differences to MDMA and a very interesting read! Rchemsport

What is the effect of benzofuran? | 6-apb succinate

The subjective effects of Benzofury are generally described as very similar to those of MDMA and 5-MAPB.

It is often perceived as slightly more stimulating than 5-MAPB, while 5-MAPB is usually described as more euphoric.

6-APB has a significantly longer effect than MDMA. Most experiments typically last between 7 and 10 hours.

The duration of effect of MDMA is three to six hours, which often leads to compulsive post-dosing. Both 5-MAPB and benzofurans are generally reported to have a less severe comedown than MDMA.

The most commonly reported effects of 6 APB include:

Stimulation and sedation
Spontaneous physical sensations
Feelings of connectedness and increased empathy
Increased stamina
Color enhancement

Possible side effects are

Increased body temperature
Stronger vision
Increased sweating
Dehydration
Dry mouth
Difficulties urinating
Pupil dilation
Temporary erectile dysfunction
Teeth grinding
Fear
Appetite suppressant
Legality

6-APB is illegal in: | Benzofuran

Australia and New Zealand
Canada
Germany
Italy
Sweden
Switzerland
Turkey
Great Britain
USA

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.